rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Thomas I. H. Dubin

Director

Company insider

Files Form 4 as: Director, Intensity Therapeutics; Director, Notable Labs; SVP & Chief Legal Officer, Alexion Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
192
Buys
0
Sells
42
Bought
$0
Sold
$64.8M
Companies
3
Companies where not an officer
2
First trade
9 Jan 2006
Last trade
16 Jul 2026
Last filed
20 Jul 2026

Companies traded

Where they are an officer
Alexion PharmaceuticalsOfficer · last 23 Aug 20120 buys · 42 sells
Everywhere else they filed: board seats, 10% stakes, other companies
INTS Intensity TherapeuticsDirector · Biotechnology · last 16 Jul 20260 buys · 0 sells
Notable LabsDirector · last 8 May 20240 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
16 Jul 2026filed 20 Jul 2026INTS Intensity Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—5,500 at $0.00filing
16 Jul 2026filed 20 Jul 2026INTS Intensity Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—5,500 at $0.00filing
2 May 2025filed 6 May 2025INTS Intensity Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
14 May 2024filed 15 May 2024INTS Intensity Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
8 May 2024filed 10 May 2024Notable LabsSEC FORM 4 Code A—40,247 at $0.00filing
24 Jan 2024filed 26 Jan 2024Notable Labsoption or derivativeSEC FORM 4 Code A—9,753 at $0.00filing
23 Aug 2012filed 27 Aug 2012Alexion PharmaceuticalsSEC FORM 4 Sold$2.5M24,328 at $103.09filing
23 Aug 2012filed 27 Aug 2012Alexion PharmaceuticalsSEC FORM 4 Sold$956K9,200 at $103.87filing
31 Jul 2012filed 31 Jul 2012Alexion PharmaceuticalsSEC FORM 4 Sold$71K680 at $104.94filing
27 Jul 2012filed 31 Jul 2012Alexion Pharmaceuticalsoption or derivativeSEC FORM 4 Code M—82,671 at $0.00filing
27 Jul 2012filed 31 Jul 2012Alexion Pharmaceuticalsoption or derivativeSEC FORM 4 Code M—56,250 at $0.00filing
27 Jul 2012filed 31 Jul 2012Alexion Pharmaceuticalsoption or derivativeSEC FORM 4 Code M—28,124 at $0.00filing
27 Jul 2012filed 31 Jul 2012Alexion Pharmaceuticalsoption or derivativeSEC FORM 4 Code M—4,000 at $0.00filing
27 Jul 2012filed 31 Jul 2012Alexion PharmaceuticalsSEC FORM 4 Code M$1.5M82,671 at $17.98filing
27 Jul 2012filed 31 Jul 2012Alexion PharmaceuticalsSEC FORM 4 Code M$1.3M56,250 at $22.90filing
27 Jul 2012filed 31 Jul 2012Alexion PharmaceuticalsSEC FORM 4 Code M$1.2M28,124 at $42.66filing
27 Jul 2012filed 31 Jul 2012Alexion PharmaceuticalsSEC FORM 4 Code M$316K4,000 at $78.88filing
27 Jul 2012filed 31 Jul 2012Alexion PharmaceuticalsSEC FORM 4 Sold$663K6,268 at $105.76filing
27 Jul 2012filed 31 Jul 2012Alexion PharmaceuticalsSEC FORM 4 Sold$1.8M16,642 at $106.35filing
27 Jul 2012filed 31 Jul 2012Alexion PharmaceuticalsSEC FORM 4 Sold$5.5M51,303 at $107.57filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed42

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.